119 related articles for article (PubMed ID: 46851)
21. Automated quantitation of proteins in serum and other biologic fluids.
Ritchie RF; Alper CA; Graves J; Pearson N; Larson C
Am J Clin Pathol; 1973 Feb; 59(2):151-9. PubMed ID: 4119925
[No Abstract] [Full Text] [Related]
22. A simple method for producing a monospecific antiserum against IgM.
Houweling TA; van Pelt FG
J Immunol Methods; 1975; 8(1-2):1-8. PubMed ID: 807653
[TBL] [Abstract][Full Text] [Related]
23. Separation of C'4 from C'1 inactivator and purification of both substances.
Inai S; Hiramatsu S; Nagaki K
Biken J; 1967 Sep; 10(3):155-74. PubMed ID: 4170106
[No Abstract] [Full Text] [Related]
24. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
25. Immunological relationship of the urinary trypsin inhibitor to a plasma -globulin.
Proksch GJ; Routh JI; Smith JM; Newman BS
Clin Biochem; 1972 Dec; 5(4):242-5. PubMed ID: 4118346
[No Abstract] [Full Text] [Related]
26. Immunofluorescence of the skin in allergic diseases: an investigation of patients with contact dermatitis, allergic vasculitis and atopic dermatitis.
Secher L; Permin H; Juhl F
Acta Derm Venereol; 1978; 58(2):117-20. PubMed ID: 76388
[TBL] [Abstract][Full Text] [Related]
27. An unknown guinea-pig immunoglobulin with strong antibody activity to egg albumin.
van Es L; Kwant-den Harink H; Pondman KW
Immunology; 1973 Jun; 24(6):1087-97. PubMed ID: 4123962
[TBL] [Abstract][Full Text] [Related]
28. Purification of the first component of complement by zonal ultracentrifugation.
Colten HR; Bond HE; Borsos T; Rapp HJ
J Immunol; 1969 Oct; 103(4):862-5. PubMed ID: 4981689
[No Abstract] [Full Text] [Related]
29. Investigation of the serum level of pregnancy-associated alpha2-globulin during contraceptive treatment by means of radial immunodiffusion method.
Than GN; Csaba IF; Karg NJ; Szabo DG
Int J Fertil; 1975; 20(1):27-9. PubMed ID: 57103
[TBL] [Abstract][Full Text] [Related]
30. Immunochemical quantitation of IgG: influences of the antiserum and of the antigenic population.
Grubb A
Scand J Clin Lab Invest; 1973 Jun; 31(4):465-72. PubMed ID: 4128389
[No Abstract] [Full Text] [Related]
31. Antigenic relationship between the fourth component of human and guinea pig complement.
Ohanian SH; Borsos T
J Immunol; 1975 Jan; 114(1 Pt 1):161-4. PubMed ID: 46239
[TBL] [Abstract][Full Text] [Related]
32. Immunochemical analyses of membrane-bound complement. Detection of the terminal complement complex and its similarity to "intrinsic" erythrocyte membrane proteins.
Bhakdi S; Bjerrum OJ; Rother U; Knüfermann H; Wallach DF
Biochim Biophys Acta; 1975 Sep; 406(1):21-35. PubMed ID: 809065
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of activation of the human terminal complement pathway by ELISA.
Sanders ME; Schmetz MA; Hammer CH; Frank MM; Joiner KA
J Immunol Methods; 1985 Dec; 85(2):245-56. PubMed ID: 2416846
[TBL] [Abstract][Full Text] [Related]
34. Anti-C3a, anti-C3B (anti-B) and their reaction with the anaphylatoxic fragment C3a.
Molenaar JL; ten Velde A; Pondman KW
J Immunol; 1973 Mar; 110(3):702-8. PubMed ID: 4631868
[No Abstract] [Full Text] [Related]
35. Serum complement (beta 1C) in young children with atopic dermatitis.
Kaufman HS; Frick OL; Fink D
J Allergy; 1968 Jul; 42(1):1-8. PubMed ID: 4174465
[No Abstract] [Full Text] [Related]
36. In vivo abrogation of serum C3 and C5 by administration of cobra venom factor and heterologous anti-C3.
Drake WP; Pokorney DR; Mardiney MR
J Immunol Methods; 1974 Dec; 6(1-2):61-72. PubMed ID: 4215835
[No Abstract] [Full Text] [Related]
37. Detection, separation and characterization of organ specific antigens of human thrombocytes.
Hanna N; Nelken D
Immunology; 1971 Apr; 20(4):533-43. PubMed ID: 4101706
[TBL] [Abstract][Full Text] [Related]
38. An inherited and pregnancy-associated -globulin in Japanese sera.
Kasukawa R; Yoshida H; Yoshida T
Int Arch Allergy Appl Immunol; 1973; 44(2):302-8. PubMed ID: 4122305
[No Abstract] [Full Text] [Related]
39. The inactivator of the first component of human complement (C1INA). The complex formation with the activated first component of human complement (C1) or with its subcomponents.
Nagaki K; Iida K; Inai S
Int Arch Allergy Appl Immunol; 1974; 46(6):935-48. PubMed ID: 4210434
[No Abstract] [Full Text] [Related]
40. A method for preparing monospecific antisera to Cl esterase (Cls): microheterogeneity of purified Cls.
Nagaki K; Stroud RM
J Immunol; 1970 Jul; 105(1):162-9. PubMed ID: 4988888
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
